Viral Inception of Asthma: Prospective study from infancy to early school-age. - VIA-study

Turku University Hospital0 个研究点目标入组 140 人开始时间: 2007年1月9日最近更新: 2012年3月19日

试验速览

暂无简介。

•General Inclusion Criteria
•Age 3-24 months, be delivered at >37 weeks, first wheezing episode OR upper respiratory tract infection without wheezing, written informed consent from guardian.
•Inclusion Criteria for the Intervention
•Rhinovirus PCR positive wheezing episode and still signs of lower respiratory symptoms (cough, noisy breathing or wheezing) at the time the initiation of study drug.
•Inclusion Criteria for the Follow-up
•First wheezing episode induced by rhinovirus or RSV OR rhinovirus induced upper respiratory tract infection without wheezing, written informed consent from guardian.
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Chronic illness other than atopy, previous systemic or inhaled corticosteroid treatment, participation to another study (excluding long-term follow-up studies in childhood), varicella contact if previously intact, or poor understanding of Finnish.

发起方